Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue | 13 | 2020 | 327 | 2.100 |
Why?
|
| Pericardium | 9 | 2019 | 50 | 2.000 |
Why?
|
| Calcinosis | 4 | 2013 | 143 | 1.120 |
Why?
|
| Atherosclerosis | 11 | 2020 | 693 | 1.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2019 | 1379 | 0.880 |
Why?
|
| Ethnic Groups | 3 | 2020 | 440 | 0.810 |
Why?
|
| Coronary Artery Disease | 4 | 2013 | 359 | 0.710 |
Why?
|
| Aged | 33 | 2020 | 9487 | 0.640 |
Why?
|
| Aging | 7 | 2020 | 881 | 0.640 |
Why?
|
| Cardiovascular Diseases | 7 | 2019 | 1013 | 0.630 |
Why?
|
| Obesity | 7 | 2020 | 1063 | 0.620 |
Why?
|
| Cognition | 3 | 2020 | 526 | 0.610 |
Why?
|
| Aged, 80 and over | 19 | 2019 | 3717 | 0.600 |
Why?
|
| Lipids | 4 | 2019 | 209 | 0.580 |
Why?
|
| Body Composition | 6 | 2019 | 365 | 0.540 |
Why?
|
| Female | 37 | 2020 | 18164 | 0.520 |
Why?
|
| Cholesterol | 2 | 2019 | 229 | 0.520 |
Why?
|
| Male | 35 | 2020 | 17807 | 0.490 |
Why?
|
| Monocytes | 4 | 2017 | 119 | 0.480 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 64 | 0.480 |
Why?
|
| Middle Aged | 27 | 2020 | 10829 | 0.480 |
Why?
|
| Genome-Wide Association Study | 9 | 2020 | 543 | 0.480 |
Why?
|
| Body Mass Index | 7 | 2010 | 865 | 0.470 |
Why?
|
| Coronary Vessels | 3 | 2013 | 147 | 0.470 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 836 | 0.460 |
Why?
|
| DNA Methylation | 5 | 2019 | 130 | 0.450 |
Why?
|
| European Continental Ancestry Group | 6 | 2020 | 1131 | 0.450 |
Why?
|
| Coronary Circulation | 2 | 2011 | 30 | 0.440 |
Why?
|
| Risk Factors | 16 | 2019 | 3531 | 0.430 |
Why?
|
| Humans | 40 | 2020 | 29093 | 0.420 |
Why?
|
| Cognition Disorders | 1 | 2014 | 390 | 0.390 |
Why?
|
| Myocardium | 1 | 2011 | 170 | 0.390 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 863 | 0.370 |
Why?
|
| Cohort Studies | 9 | 2019 | 1687 | 0.370 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 1218 | 0.370 |
Why?
|
| Asian Continental Ancestry Group | 3 | 2020 | 110 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2019 | 871 | 0.340 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 28 | 0.330 |
Why?
|
| Cardiomyopathies | 1 | 2008 | 48 | 0.320 |
Why?
|
| Coronary Disease | 1 | 2009 | 200 | 0.320 |
Why?
|
| Stroke | 2 | 2017 | 545 | 0.310 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 46 | 0.290 |
Why?
|
| Cross-Sectional Studies | 5 | 2019 | 1356 | 0.290 |
Why?
|
| Haplotypes | 1 | 2006 | 220 | 0.290 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2020 | 1079 | 0.280 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 196 | 0.270 |
Why?
|
| African Continental Ancestry Group | 4 | 2019 | 350 | 0.250 |
Why?
|
| Adult | 10 | 2019 | 8420 | 0.250 |
Why?
|
| Asian Americans | 2 | 2019 | 98 | 0.240 |
Why?
|
| Hypertension | 3 | 2017 | 906 | 0.230 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 412 | 0.220 |
Why?
|
| Depression | 2 | 2018 | 380 | 0.220 |
Why?
|
| Transcription Factors | 3 | 2019 | 172 | 0.220 |
Why?
|
| Genetic Loci | 2 | 2019 | 147 | 0.200 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2020 | 17 | 0.200 |
Why?
|
| Multifactorial Inheritance | 1 | 2020 | 19 | 0.190 |
Why?
|
| Mutation, Missense | 1 | 2020 | 48 | 0.190 |
Why?
|
| Incidence | 7 | 2020 | 1119 | 0.190 |
Why?
|
| Metformin | 1 | 2020 | 19 | 0.190 |
Why?
|
| Coronary Angiography | 2 | 2013 | 136 | 0.190 |
Why?
|
| Muscular Atrophy | 2 | 2012 | 67 | 0.180 |
Why?
|
| Fibroblast Growth Factors | 1 | 2019 | 34 | 0.180 |
Why?
|
| Heart Failure | 2 | 2020 | 568 | 0.180 |
Why?
|
| Fats | 1 | 2019 | 2 | 0.180 |
Why?
|
| Inflammation | 3 | 2020 | 507 | 0.170 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 176 | 0.170 |
Why?
|
| Gene Expression | 2 | 2017 | 332 | 0.150 |
Why?
|
| Brain | 2 | 2014 | 930 | 0.150 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 142 | 0.150 |
Why?
|
| Carrier Proteins | 1 | 2017 | 131 | 0.140 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 244 | 0.140 |
Why?
|
| Liver | 1 | 2019 | 464 | 0.140 |
Why?
|
| Exercise | 2 | 2019 | 591 | 0.140 |
Why?
|
| Smoking | 1 | 2019 | 427 | 0.130 |
Why?
|
| Gene Dosage | 1 | 2015 | 34 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 481 | 0.130 |
Why?
|
| Waist Circumference | 3 | 2010 | 89 | 0.130 |
Why?
|
| Sex Factors | 2 | 2017 | 631 | 0.130 |
Why?
|
| Linear Models | 4 | 2010 | 426 | 0.130 |
Why?
|
| Weight Loss | 2 | 2015 | 413 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 47 | 0.130 |
Why?
|
| Aortic Diseases | 2 | 2013 | 54 | 0.120 |
Why?
|
| Aorta, Thoracic | 2 | 2013 | 72 | 0.120 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 720 | 0.120 |
Why?
|
| Intra-Abdominal Fat | 2 | 2011 | 61 | 0.120 |
Why?
|
| Phenotype | 3 | 2020 | 629 | 0.120 |
Why?
|
| Blood Pressure | 2 | 2017 | 804 | 0.120 |
Why?
|
| Hypercholesterolemia | 1 | 2014 | 59 | 0.120 |
Why?
|
| Aortography | 1 | 2013 | 16 | 0.120 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 379 | 0.110 |
Why?
|
| Genotype | 3 | 2019 | 735 | 0.110 |
Why?
|
| Pharyngeal Muscles | 1 | 2012 | 4 | 0.110 |
Why?
|
| Deglutition | 1 | 2012 | 28 | 0.110 |
Why?
|
| Prospective Studies | 5 | 2013 | 2019 | 0.110 |
Why?
|
| Perfusion | 1 | 2011 | 64 | 0.100 |
Why?
|
| African Americans | 2 | 2010 | 1373 | 0.100 |
Why?
|
| Hemodynamics | 1 | 2011 | 148 | 0.100 |
Why?
|
| Health Status | 1 | 2013 | 368 | 0.100 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 98 | 0.090 |
Why?
|
| Abdominal Fat | 1 | 2010 | 46 | 0.090 |
Why?
|
| Prognosis | 1 | 2014 | 1362 | 0.090 |
Why?
|
| Caloric Restriction | 1 | 2011 | 92 | 0.090 |
Why?
|
| Tunica Media | 1 | 2010 | 29 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 637 | 0.090 |
Why?
|
| Risk Assessment | 3 | 2013 | 1305 | 0.090 |
Why?
|
| Tunica Intima | 1 | 2010 | 59 | 0.090 |
Why?
|
| Carotid Artery, Common | 1 | 2010 | 37 | 0.090 |
Why?
|
| Carotid Artery, Internal | 1 | 2010 | 29 | 0.090 |
Why?
|
| Heart Atria | 1 | 2010 | 62 | 0.090 |
Why?
|
| C-Reactive Protein | 2 | 2017 | 232 | 0.090 |
Why?
|
| Cerebrovascular Disorders | 1 | 2010 | 48 | 0.090 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 709 | 0.090 |
Why?
|
| Postmenopause | 1 | 2011 | 397 | 0.090 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 40 | 0.080 |
Why?
|
| Cholesterol, HDL | 2 | 2019 | 165 | 0.080 |
Why?
|
| Waist-Hip Ratio | 1 | 2008 | 33 | 0.080 |
Why?
|
| Cholesterol, LDL | 2 | 2019 | 157 | 0.080 |
Why?
|
| Triglycerides | 2 | 2019 | 214 | 0.080 |
Why?
|
| Young Adult | 3 | 2019 | 2402 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 130 | 0.080 |
Why?
|
| Hispanic Americans | 2 | 2019 | 904 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 136 | 0.080 |
Why?
|
| Dietary Proteins | 1 | 2008 | 50 | 0.080 |
Why?
|
| Health Surveys | 1 | 2008 | 191 | 0.080 |
Why?
|
| Mobility Limitation | 1 | 2009 | 187 | 0.080 |
Why?
|
| Body Size | 1 | 2007 | 31 | 0.070 |
Why?
|
| Overweight | 1 | 2009 | 256 | 0.070 |
Why?
|
| Adolescent | 3 | 2019 | 3254 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2009 | 859 | 0.070 |
Why?
|
| Life Style | 2 | 2019 | 364 | 0.070 |
Why?
|
| Continental Population Groups | 2 | 2019 | 221 | 0.070 |
Why?
|
| Skin | 1 | 2008 | 203 | 0.070 |
Why?
|
| Kidney | 1 | 2010 | 485 | 0.070 |
Why?
|
| Alleles | 1 | 2006 | 251 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 212 | 0.070 |
Why?
|
| Adiposity | 3 | 2011 | 191 | 0.060 |
Why?
|
| Organ Size | 2 | 2019 | 196 | 0.060 |
Why?
|
| United States | 4 | 2019 | 3630 | 0.060 |
Why?
|
| CpG Islands | 2 | 2015 | 44 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 320 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 494 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2003 | 225 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 200 | 0.050 |
Why?
|
| Age Factors | 3 | 2011 | 1108 | 0.050 |
Why?
|
| Genetics | 1 | 2020 | 4 | 0.050 |
Why?
|
| Interleukin-7 | 1 | 2020 | 11 | 0.050 |
Why?
|
| Goblet Cells | 1 | 2020 | 5 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 35 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2020 | 34 | 0.050 |
Why?
|
| Mucins | 1 | 2020 | 18 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 53 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2019 | 5 | 0.040 |
Why?
|
| Antihypertensive Agents | 2 | 2014 | 339 | 0.040 |
Why?
|
| Asia | 1 | 2019 | 17 | 0.040 |
Why?
|
| Brazil | 1 | 2019 | 13 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 33 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 45 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2019 | 57 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2019 | 192 | 0.040 |
Why?
|
| Prediabetic State | 1 | 2019 | 54 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 100 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 118 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2020 | 278 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2017 | 9 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 9 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 417 | 0.040 |
Why?
|
| Histones | 1 | 2017 | 49 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2019 | 256 | 0.040 |
Why?
|
| Lysine | 1 | 2017 | 24 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 2017 | 94 | 0.040 |
Why?
|
| North Carolina | 2 | 2011 | 1423 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 787 | 0.040 |
Why?
|
| Absorptiometry, Photon | 2 | 2008 | 129 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 980 | 0.040 |
Why?
|
| Prevalence | 1 | 2019 | 896 | 0.040 |
Why?
|
| Ribosomes | 1 | 2015 | 10 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2015 | 22 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 46 | 0.030 |
Why?
|
| Heart Rate | 1 | 2017 | 315 | 0.030 |
Why?
|
| Autophagy | 1 | 2015 | 53 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 114 | 0.030 |
Why?
|
| Mice | 1 | 2020 | 2368 | 0.030 |
Why?
|
| Genome, Human | 1 | 2014 | 129 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2013 | 10 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2013 | 18 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2013 | 23 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2013 | 18 | 0.030 |
Why?
|
| Heart Valve Diseases | 1 | 2013 | 25 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2013 | 85 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 15 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 149 | 0.030 |
Why?
|
| Velopharyngeal Sphincter | 1 | 2012 | 4 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2013 | 47 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2013 | 28 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 293 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 126 | 0.030 |
Why?
|
| Head | 1 | 2012 | 47 | 0.030 |
Why?
|
| Cause of Death | 1 | 2013 | 220 | 0.030 |
Why?
|
| Deglutition Disorders | 1 | 2012 | 50 | 0.030 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2011 | 13 | 0.030 |
Why?
|
| Radiography | 1 | 2012 | 353 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 64 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 138 | 0.020 |
Why?
|
| Aorta | 1 | 2010 | 103 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2006 | 2108 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 140 | 0.020 |
Why?
|
| Age Distribution | 1 | 2009 | 198 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2008 | 106 | 0.020 |
Why?
|
| Animals | 1 | 2020 | 7297 | 0.020 |
Why?
|
| Contrast Media | 1 | 2008 | 123 | 0.020 |
Why?
|
| Meat | 1 | 2008 | 15 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 2001 | 0.020 |
Why?
|
| Nutrition Assessment | 1 | 2008 | 54 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2010 | 345 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 532 | 0.020 |
Why?
|
| Comorbidity | 1 | 2008 | 540 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 726 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2014 | 3099 | 0.020 |
Why?
|
| Body Fat Distribution | 1 | 2006 | 34 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2012 | 3111 | 0.020 |
Why?
|